Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Logo de l'unité RnD

Technology platforms

Technology Excellence for Research and Patients

Retour à la recherche

The technological platforms of Paris Brain Institute are specialized units that put their equipment and skills at the service of academic and private research teams.

Introduction

Introduction

The human brain is a complex and unique organ. Understanding how it works and the pathologies associated with it requires acquiring data at every level of organization (molecular, cellular, neuronal...) and at every moment. Paris Brain Institute provides its research teams with the instrumental and organizational means to achieve their goals.

Since its inception, Paris Brain Institute has been structured around the pooling of high-level technological and human resources necessary for the development of research by creating dedicated technological platforms.

Beyond the provision of innovative equipment, the main mission of the technological platforms of Paris Brain Institute is the pooling of skills and the provision of services and expertise for the entire scientific community: research teams of Paris Brain Institute, external academic teams, incubated companies, external companies, etc.
 

How are the platforms organised?

How are the platforms organised?

Each platform is thus led by an operational manager and a scientific manager. The scientific leader is an expert in the field of the platform and is responsible for forward and strategic thinking. The operational manager is responsible for the actual operation of the platform, its operational staff, the reliability of services and customer satisfaction. It is also responsible for interaction with the administrative services of the Institute.
 

A comprehensive and diversified offer
A comprehensive and diversified offer

Paris Brain Institute platforms offer two types of services:

  • Equipment, with the training of users in the use of equipment or in the implementation of different techniques.
  • Service delivery, from design to outcome analysis.

News that might interest you

L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Artificial Intelligence, data Science and computational science: call for expression of interest for Senior and Mid-Career Researchers
Artificial Intelligence, data Science and computational science: call for expression of interest for Senior and Mid-Career Researchers
Artificial intelligence is rapidly transforming the way scientists explore the human brain. To accelerate breakthroughs, the Paris Brain Institute is launching, after its Call for Junior Group Leaders, a Call for Expression of Interest for Senior or...
03.09.2026 Institutional
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
See all our news